ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ophthalmic Medicine Market Research Report 2024
Published Date: July 2024
|
Report Code: QYRE-Auto-13H8167
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global and Japan Ophthalmic Medicine Market Insights Forecast to 2027
BUY CHAPTERS

Global Ophthalmic Medicine Market Research Report 2024

Code: QYRE-Auto-13H8167
Report
July 2024
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novaliq
Shenyang Xingqi Pharmaceutical Co.,Ltd.
Zhejiang Shapuaisi Pharmaceutical
Chengdu Kanghong Pharmaceutical Group
Santen Pharmaceutica
Bausch Health
Alcon
Mentholatum

Ophthalmic Medicine Market Size

The global Ophthalmic Medicine market was valued at US$ 1897 million in 2023 and is anticipated to reach US$ 2545 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.

Ophthalmic Medicine Market

Ophthalmic Medicine Market

There are several diseases that can affect the eyes, and often, the kind of treatment required is medication that you put directly into them. It is called “ophthalmic” and often comes in the form of drops, gel or ointment.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Medicine.

Report Scope

The Ophthalmic Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ophthalmic Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ophthalmic Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Ophthalmic Medicine Market Report

Report Metric Details
Report Name Ophthalmic Medicine Market
Accounted market size in 2023 US$ 1897 million
Forecasted market size in 2030 US$ 2545 million
CAGR 4.8%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Eye Drops
  • Eye Ointment
  • Gelling Agent
  • Tablet
  • Injection
Segment by Application
  • Anti-fatigue and Dryness
  • Cataract
  • Anti-infective
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novaliq, Shenyang Xingqi Pharmaceutical Co.,Ltd., Zhejiang Shapuaisi Pharmaceutical, Chengdu Kanghong Pharmaceutical Group, Santen Pharmaceutica, Bausch Health, Alcon NV, Mentholatum
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Ophthalmic Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Ophthalmic Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Ophthalmic Medicine Market growing?

Ans: The Ophthalmic Medicine Market witnessing a CAGR of 4.8% during the forecast period 2024-2030.

What is the Ophthalmic Medicine Market size in 2030?

Ans: The Ophthalmic Medicine Market size in 2030 will be US$ 2545 million.

Who are the main players in the Ophthalmic Medicine Market report?

Ans: The main players in the Ophthalmic Medicine Market are Novaliq, Shenyang Xingqi Pharmaceutical Co.,Ltd., Zhejiang Shapuaisi Pharmaceutical, Chengdu Kanghong Pharmaceutical Group, Santen Pharmaceutica, Bausch Health, Alcon NV, Mentholatum

What are the Application segmentation covered in the Ophthalmic Medicine Market report?

Ans: The Applications covered in the Ophthalmic Medicine Market report are Anti-fatigue and Dryness, Cataract, Anti-infective

What are the Type segmentation covered in the Ophthalmic Medicine Market report?

Ans: The Types covered in the Ophthalmic Medicine Market report are Eye Drops, Eye Ointment, Gelling Agent, Tablet, Injection

1 Ophthalmic Medicine Market Overview
1.1 Product Overview and Scope of Ophthalmic Medicine
1.2 Ophthalmic Medicine Segment by Type
1.2.1 Global Ophthalmic Medicine Market Value Comparison by Type (2024-2030)
1.2.2 Eye Drops
1.2.3 Eye Ointment
1.2.4 Gelling Agent
1.2.5 Tablet
1.2.6 Injection
1.3 Ophthalmic Medicine Segment by Application
1.3.1 Global Ophthalmic Medicine Market Value by Application: (2024-2030)
1.3.2 Anti-fatigue and Dryness
1.3.3 Cataract
1.3.4 Anti-infective
1.4 Global Ophthalmic Medicine Market Size Estimates and Forecasts
1.4.1 Global Ophthalmic Medicine Revenue 2019-2030
1.4.2 Global Ophthalmic Medicine Sales 2019-2030
1.4.3 Global Ophthalmic Medicine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ophthalmic Medicine Market Competition by Manufacturers
2.1 Global Ophthalmic Medicine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ophthalmic Medicine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ophthalmic Medicine Average Price by Manufacturers (2019-2024)
2.4 Global Ophthalmic Medicine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ophthalmic Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ophthalmic Medicine, Product Type & Application
2.7 Ophthalmic Medicine Market Competitive Situation and Trends
2.7.1 Ophthalmic Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ophthalmic Medicine Players Market Share by Revenue
2.7.3 Global Ophthalmic Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ophthalmic Medicine Retrospective Market Scenario by Region
3.1 Global Ophthalmic Medicine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ophthalmic Medicine Global Ophthalmic Medicine Sales by Region: 2019-2030
3.2.1 Global Ophthalmic Medicine Sales by Region: 2019-2024
3.2.2 Global Ophthalmic Medicine Sales by Region: 2025-2030
3.3 Global Ophthalmic Medicine Global Ophthalmic Medicine Revenue by Region: 2019-2030
3.3.1 Global Ophthalmic Medicine Revenue by Region: 2019-2024
3.3.2 Global Ophthalmic Medicine Revenue by Region: 2025-2030
3.4 North America Ophthalmic Medicine Market Facts & Figures by Country
3.4.1 North America Ophthalmic Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ophthalmic Medicine Sales by Country (2019-2030)
3.4.3 North America Ophthalmic Medicine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ophthalmic Medicine Market Facts & Figures by Country
3.5.1 Europe Ophthalmic Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ophthalmic Medicine Sales by Country (2019-2030)
3.5.3 Europe Ophthalmic Medicine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ophthalmic Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Ophthalmic Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ophthalmic Medicine Sales by Country (2019-2030)
3.6.3 Asia Pacific Ophthalmic Medicine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Ophthalmic Medicine Market Facts & Figures by Country
3.7.1 Latin America Ophthalmic Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ophthalmic Medicine Sales by Country (2019-2030)
3.7.3 Latin America Ophthalmic Medicine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ophthalmic Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Ophthalmic Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ophthalmic Medicine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ophthalmic Medicine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ophthalmic Medicine Sales by Type (2019-2030)
4.1.1 Global Ophthalmic Medicine Sales by Type (2019-2024)
4.1.2 Global Ophthalmic Medicine Sales by Type (2025-2030)
4.1.3 Global Ophthalmic Medicine Sales Market Share by Type (2019-2030)
4.2 Global Ophthalmic Medicine Revenue by Type (2019-2030)
4.2.1 Global Ophthalmic Medicine Revenue by Type (2019-2024)
4.2.2 Global Ophthalmic Medicine Revenue by Type (2025-2030)
4.2.3 Global Ophthalmic Medicine Revenue Market Share by Type (2019-2030)
4.3 Global Ophthalmic Medicine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ophthalmic Medicine Sales by Application (2019-2030)
5.1.1 Global Ophthalmic Medicine Sales by Application (2019-2024)
5.1.2 Global Ophthalmic Medicine Sales by Application (2025-2030)
5.1.3 Global Ophthalmic Medicine Sales Market Share by Application (2019-2030)
5.2 Global Ophthalmic Medicine Revenue by Application (2019-2030)
5.2.1 Global Ophthalmic Medicine Revenue by Application (2019-2024)
5.2.2 Global Ophthalmic Medicine Revenue by Application (2025-2030)
5.2.3 Global Ophthalmic Medicine Revenue Market Share by Application (2019-2030)
5.3 Global Ophthalmic Medicine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novaliq
6.1.1 Novaliq Corporation Information
6.1.2 Novaliq Description and Business Overview
6.1.3 Novaliq Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novaliq Ophthalmic Medicine Product Portfolio
6.1.5 Novaliq Recent Developments/Updates
6.2 Shenyang Xingqi Pharmaceutical Co.,Ltd.
6.2.1 Shenyang Xingqi Pharmaceutical Co.,Ltd. Corporation Information
6.2.2 Shenyang Xingqi Pharmaceutical Co.,Ltd. Description and Business Overview
6.2.3 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Portfolio
6.2.5 Shenyang Xingqi Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.3 Zhejiang Shapuaisi Pharmaceutical
6.3.1 Zhejiang Shapuaisi Pharmaceutical Corporation Information
6.3.2 Zhejiang Shapuaisi Pharmaceutical Description and Business Overview
6.3.3 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Portfolio
6.3.5 Zhejiang Shapuaisi Pharmaceutical Recent Developments/Updates
6.4 Chengdu Kanghong Pharmaceutical Group
6.4.1 Chengdu Kanghong Pharmaceutical Group Corporation Information
6.4.2 Chengdu Kanghong Pharmaceutical Group Description and Business Overview
6.4.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Portfolio
6.4.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
6.5 Santen Pharmaceutica
6.5.1 Santen Pharmaceutica Corporation Information
6.5.2 Santen Pharmaceutica Description and Business Overview
6.5.3 Santen Pharmaceutica Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Santen Pharmaceutica Ophthalmic Medicine Product Portfolio
6.5.5 Santen Pharmaceutica Recent Developments/Updates
6.6 Bausch Health
6.6.1 Bausch Health Corporation Information
6.6.2 Bausch Health Description and Business Overview
6.6.3 Bausch Health Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bausch Health Ophthalmic Medicine Product Portfolio
6.6.5 Bausch Health Recent Developments/Updates
6.7 Alcon NV
6.6.1 Alcon NV Corporation Information
6.6.2 Alcon NV Description and Business Overview
6.6.3 Alcon NV Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Alcon NV Ophthalmic Medicine Product Portfolio
6.7.5 Alcon NV Recent Developments/Updates
6.8 Mentholatum
6.8.1 Mentholatum Corporation Information
6.8.2 Mentholatum Description and Business Overview
6.8.3 Mentholatum Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mentholatum Ophthalmic Medicine Product Portfolio
6.8.5 Mentholatum Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ophthalmic Medicine Industry Chain Analysis
7.2 Ophthalmic Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ophthalmic Medicine Production Mode & Process
7.4 Ophthalmic Medicine Sales and Marketing
7.4.1 Ophthalmic Medicine Sales Channels
7.4.2 Ophthalmic Medicine Distributors
7.5 Ophthalmic Medicine Customers
8 Ophthalmic Medicine Market Dynamics
8.1 Ophthalmic Medicine Industry Trends
8.2 Ophthalmic Medicine Market Drivers
8.3 Ophthalmic Medicine Market Challenges
8.4 Ophthalmic Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novaliq
Shenyang Xingqi Pharmaceutical Co.,Ltd.
Zhejiang Shapuaisi Pharmaceutical
Chengdu Kanghong Pharmaceutical Group
Santen Pharmaceutica
Bausch Health
Alcon
Mentholatum
List of Tables
    Table 1. Global Ophthalmic Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Ophthalmic Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Ophthalmic Medicine Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Ophthalmic Medicine Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Ophthalmic Medicine Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Ophthalmic Medicine Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Ophthalmic Medicine Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Ophthalmic Medicine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Ophthalmic Medicine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Ophthalmic Medicine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Ophthalmic Medicine, Product Type & Application
    Table 12. Global Key Manufacturers of Ophthalmic Medicine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Ophthalmic Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Medicine as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Ophthalmic Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Ophthalmic Medicine Sales by Region (2019-2024) & (K Units)
    Table 18. Global Ophthalmic Medicine Sales Market Share by Region (2019-2024)
    Table 19. Global Ophthalmic Medicine Sales by Region (2025-2030) & (K Units)
    Table 20. Global Ophthalmic Medicine Sales Market Share by Region (2025-2030)
    Table 21. Global Ophthalmic Medicine Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Ophthalmic Medicine Revenue Market Share by Region (2019-2024)
    Table 23. Global Ophthalmic Medicine Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Ophthalmic Medicine Revenue Market Share by Region (2025-2030)
    Table 25. North America Ophthalmic Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Ophthalmic Medicine Sales by Country (2019-2024) & (K Units)
    Table 27. North America Ophthalmic Medicine Sales by Country (2025-2030) & (K Units)
    Table 28. North America Ophthalmic Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Ophthalmic Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Ophthalmic Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Ophthalmic Medicine Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Ophthalmic Medicine Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Ophthalmic Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Ophthalmic Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Ophthalmic Medicine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Ophthalmic Medicine Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Ophthalmic Medicine Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Ophthalmic Medicine Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Ophthalmic Medicine Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Ophthalmic Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Ophthalmic Medicine Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Ophthalmic Medicine Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Ophthalmic Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Ophthalmic Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Ophthalmic Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Ophthalmic Medicine Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Ophthalmic Medicine Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Ophthalmic Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Ophthalmic Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Ophthalmic Medicine Sales (K Units) by Type (2019-2024)
    Table 51. Global Ophthalmic Medicine Sales (K Units) by Type (2025-2030)
    Table 52. Global Ophthalmic Medicine Sales Market Share by Type (2019-2024)
    Table 53. Global Ophthalmic Medicine Sales Market Share by Type (2025-2030)
    Table 54. Global Ophthalmic Medicine Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Ophthalmic Medicine Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Ophthalmic Medicine Revenue Market Share by Type (2019-2024)
    Table 57. Global Ophthalmic Medicine Revenue Market Share by Type (2025-2030)
    Table 58. Global Ophthalmic Medicine Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Ophthalmic Medicine Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Ophthalmic Medicine Sales (K Units) by Application (2019-2024)
    Table 61. Global Ophthalmic Medicine Sales (K Units) by Application (2025-2030)
    Table 62. Global Ophthalmic Medicine Sales Market Share by Application (2019-2024)
    Table 63. Global Ophthalmic Medicine Sales Market Share by Application (2025-2030)
    Table 64. Global Ophthalmic Medicine Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Ophthalmic Medicine Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Ophthalmic Medicine Revenue Market Share by Application (2019-2024)
    Table 67. Global Ophthalmic Medicine Revenue Market Share by Application (2025-2030)
    Table 68. Global Ophthalmic Medicine Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Ophthalmic Medicine Price (US$/Unit) by Application (2025-2030)
    Table 70. Novaliq Corporation Information
    Table 71. Novaliq Description and Business Overview
    Table 72. Novaliq Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Novaliq Ophthalmic Medicine Product
    Table 74. Novaliq Recent Developments/Updates
    Table 75. Shenyang Xingqi Pharmaceutical Co.,Ltd. Corporation Information
    Table 76. Shenyang Xingqi Pharmaceutical Co.,Ltd. Description and Business Overview
    Table 77. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product
    Table 79. Shenyang Xingqi Pharmaceutical Co.,Ltd. Recent Developments/Updates
    Table 80. Zhejiang Shapuaisi Pharmaceutical Corporation Information
    Table 81. Zhejiang Shapuaisi Pharmaceutical Description and Business Overview
    Table 82. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product
    Table 84. Zhejiang Shapuaisi Pharmaceutical Recent Developments/Updates
    Table 85. Chengdu Kanghong Pharmaceutical Group Corporation Information
    Table 86. Chengdu Kanghong Pharmaceutical Group Description and Business Overview
    Table 87. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product
    Table 89. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
    Table 90. Santen Pharmaceutica Corporation Information
    Table 91. Santen Pharmaceutica Description and Business Overview
    Table 92. Santen Pharmaceutica Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Santen Pharmaceutica Ophthalmic Medicine Product
    Table 94. Santen Pharmaceutica Recent Developments/Updates
    Table 95. Bausch Health Corporation Information
    Table 96. Bausch Health Description and Business Overview
    Table 97. Bausch Health Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Bausch Health Ophthalmic Medicine Product
    Table 99. Bausch Health Recent Developments/Updates
    Table 100. Alcon NV Corporation Information
    Table 101. Alcon NV Description and Business Overview
    Table 102. Alcon NV Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Alcon NV Ophthalmic Medicine Product
    Table 104. Alcon NV Recent Developments/Updates
    Table 105. Mentholatum Corporation Information
    Table 106. Mentholatum Description and Business Overview
    Table 107. Mentholatum Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Mentholatum Ophthalmic Medicine Product
    Table 109. Mentholatum Recent Developments/Updates
    Table 110. Key Raw Materials Lists
    Table 111. Raw Materials Key Suppliers Lists
    Table 112. Ophthalmic Medicine Distributors List
    Table 113. Ophthalmic Medicine Customers List
    Table 114. Ophthalmic Medicine Market Trends
    Table 115. Ophthalmic Medicine Market Drivers
    Table 116. Ophthalmic Medicine Market Challenges
    Table 117. Ophthalmic Medicine Market Restraints
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Ophthalmic Medicine
    Figure 2. Global Ophthalmic Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Ophthalmic Medicine Market Share by Type in 2023 & 2030
    Figure 4. Eye Drops Product Picture
    Figure 5. Eye Ointment Product Picture
    Figure 6. Gelling Agent Product Picture
    Figure 7. Tablet Product Picture
    Figure 8. Injection Product Picture
    Figure 9. Global Ophthalmic Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 10. Global Ophthalmic Medicine Market Share by Application in 2023 & 2030
    Figure 11. Anti-fatigue and Dryness
    Figure 12. Cataract
    Figure 13. Anti-infective
    Figure 14. Global Ophthalmic Medicine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Ophthalmic Medicine Market Size (2019-2030) & (US$ Million)
    Figure 16. Global Ophthalmic Medicine Sales (2019-2030) & (K Units)
    Figure 17. Global Ophthalmic Medicine Average Price (US$/Unit) & (2019-2030)
    Figure 18. Ophthalmic Medicine Report Years Considered
    Figure 19. Ophthalmic Medicine Sales Share by Manufacturers in 2023
    Figure 20. Global Ophthalmic Medicine Revenue Share by Manufacturers in 2023
    Figure 21. The Global 5 and 10 Largest Ophthalmic Medicine Players: Market Share by Revenue in 2023
    Figure 22. Ophthalmic Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 23. Global Ophthalmic Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 24. North America Ophthalmic Medicine Sales Market Share by Country (2019-2030)
    Figure 25. North America Ophthalmic Medicine Revenue Market Share by Country (2019-2030)
    Figure 26. United States Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Canada Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Europe Ophthalmic Medicine Sales Market Share by Country (2019-2030)
    Figure 29. Europe Ophthalmic Medicine Revenue Market Share by Country (2019-2030)
    Figure 30. Germany Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. France Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. U.K. Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Italy Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Russia Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Ophthalmic Medicine Sales Market Share by Region (2019-2030)
    Figure 36. Asia Pacific Ophthalmic Medicine Revenue Market Share by Region (2019-2030)
    Figure 37. China Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Japan Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. South Korea Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. India Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Australia Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Indonesia Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Thailand Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Malaysia Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Latin America Ophthalmic Medicine Sales Market Share by Country (2019-2030)
    Figure 47. Latin America Ophthalmic Medicine Revenue Market Share by Country (2019-2030)
    Figure 48. Mexico Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Brazil Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Argentina Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Middle East & Africa Ophthalmic Medicine Sales Market Share by Country (2019-2030)
    Figure 52. Middle East & Africa Ophthalmic Medicine Revenue Market Share by Country (2019-2030)
    Figure 53. Turkey Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. UAE Ophthalmic Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Global Sales Market Share of Ophthalmic Medicine by Type (2019-2030)
    Figure 57. Global Revenue Market Share of Ophthalmic Medicine by Type (2019-2030)
    Figure 58. Global Ophthalmic Medicine Price (US$/Unit) by Type (2019-2030)
    Figure 59. Global Sales Market Share of Ophthalmic Medicine by Application (2019-2030)
    Figure 60. Global Revenue Market Share of Ophthalmic Medicine by Application (2019-2030)
    Figure 61. Global Ophthalmic Medicine Price (US$/Unit) by Application (2019-2030)
    Figure 62. Ophthalmic Medicine Value Chain
    Figure 63. Ophthalmic Medicine Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Immune Thrombocytopenia Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-24G3922
Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Muscle Relaxants Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28K7363
Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Intrathecal Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-0G14265
Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Drugs for Short Bowel Syndrome - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-19D6153
Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions